Stocktoria

INTEGRA LIFESCIENCES HOLDINGS CORP IART

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1995-08-16 · LEI

INTEGRA LIFESCIENCES HOLDINGS CORP statistics & valuation

P / S0.9×
P / B1.4×
Net margin-31.6%
FCF margin-1.9%
Net debt$491.5M
Enterprise value USD$2.0B
Earnings yield EBIT/EV-25.3%
Return on capital-15.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
7.50% 5.40% 4.10% 3.30% 9.80% 11.00% 11.60% 4.40% -0.40% -31.60% 2016201720182019202020212022202320242025
Gross margin (%)
64.80% 63.30% 61.20% 62.80% 62.00% 2016201720182019202020212022202320242025
Operating margin (%)
11.60% 3.80% 7.50% 6.20% 11.00% 12.80% 15.30% 7.20% 1.80% -30.20% 2016201720182019202020212022202320242025
Return on equity (%)
8.90% 6.70% 4.40% 3.50% 8.80% 10.00% 10.00% 4.30% -0.40% -49.50% 2016201720182019202020212022202320242025
Shares outstanding
79.2M 79.1M 84.0M 86.5M 85.2M 85.5M 83.5M 80.3M 77.0M 76.7M 2016201720182019202020212022202320242025
Net debt ($)
$761.2M $678.6M $407.3M $330.3M $318.3M $498.6M $514.1M $491.5M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
4.10% 2.00% 2.00% 1.50% 3.70% 4.50% 4.60% 1.80% -0.20% -14.30% 2016201720182019202020212022202320242025
Free cash flow margin (%)
7.00% 6.00% 8.30% 10.70% 12.00% 17.10% 14.30% 4.70% 1.60% -1.90% 2016201720182019202020212022202320242025
Debt / equity (×)
0.65× 0.62× 0.58× 0.50× 0.43× 0.49× 0.49× 0.70× 2016201720182019202020212022202320242025
EPS ($)
$0.94 $0.82 $0.72 $0.58 $1.57 $1.98 $2.16 $0.84 -$0.09 -$6.74 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

INTEGRA LIFESCIENCES HOLDINGS CORP trades at about 20.7× earnings — below its 10-year norm (10-year range 26.5×–94.9×, median 47.8×).

20.7× 94.9×

Shaded band = 10-year range (26.5×–94.9×); dot = today's 20.7×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin62.0%62.8%61.2%63.3%64.8%
Operating margin-30.2%1.8%7.2%15.3%12.8%11.0%6.2%7.5%3.8%11.6%
Net margin-31.6%-0.4%4.4%11.6%11.0%9.8%3.3%4.1%5.4%7.5%
FCF margin-1.9%1.6%4.7%14.3%17.1%12.0%10.7%8.3%6.0%7.0%
Return on assets-14.3%-0.2%1.8%4.6%4.5%3.7%1.5%2.0%2.0%4.1%
Return on equity-49.5%-0.4%4.3%10.0%10.0%8.8%3.5%4.4%6.7%8.9%
Debt / equity0.70×0.49×0.49×0.43×0.50×0.58×0.62×0.65×
Current ratio2.541.173.453.623.393.092.592.952.364.01

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.